ETON
Eton Pharmaceuticals Inc

5,704
Mkt Cap
$608.99M
Volume
896,998.00
52W High
$23.00
52W Low
$11.09
PE Ratio
-124.83
ETON Fundamentals
Price
$22.32
Prev Close
$20.77
Open
$21.40
50D MA
$16.72
Beta
0.78
Avg. Volume
316,859.16
EPS (Annual)
-$0.171
P/B
23.08
Rev/Employee
$1.82M
$460.15
Loading...
Loading...

Earnings Recap

Eton Pharmaceuticals reported total net revenues of $79.95M for the twelve months ended December 31, 2025, an increase from $39.01M in 2024, resulting in a gross profit of $42.74M.

Bullish

Eton Pharmaceuticals expanded its product portfolio with eight commercial rare disease products and five late-stage candidates, driving increased revenues and gross profit, supported by strong business development and regulatory expertise.

Bearish

Eton Pharmaceuticals faces revenue constraints from healthcare reforms and PBM practices, intense competition in rare disease markets, and significant risks from intellectual property litigation and protection challenges.

Latest ETON News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.